Original Research

Published on 11 Sep 2024

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

in Cancer Immunity and Immunotherapy

Xiaodong Niu
Tao Chang
Yuekang Zhang
Yanhui Liu
Yuan Yang
Qing Mao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447879

749 views

Mini Review

Published on 10 Sep 2024

Small molecule innate immune modulators in cancer therapy

in Cancer Immunity and Immunotherapy

Avijit Goswami
Sandeep Goyal
Princy Khurana
Kawaljit Singh
Barnali Deb
Aditya Kulkarni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395655

1,450 views

Original Research

Published on 09 Sep 2024

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma

in Cancer Immunity and Immunotherapy

Irina Larionova
Pavel Iamshchikov
Anna Kazakova
Militsa Rakina
Maxim Menyalo
Kadriia Enikeeva
Guzel Rafikova
Yuliya Sharifyanova
Valentin Pavlov
Alisa Villert

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414716

1,759 views

Original Research

Published on 09 Sep 2024

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

in Cancer Immunity and Immunotherapy

Ningning Lu
Shugui Sheng
Yiqi Xiong
Chuanren Zhao
Wenying Qiao
Xiaoyan Ding
Jinglong Chen
Yonghong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459740

1,278 views

Review

Published on 09 Sep 2024

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

in Cancer Immunity and Immunotherapy

Beibei Liu
Ling Liu
Yang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450487

1,869 views

Original Research

Published on 09 Sep 2024

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States

in Cancer Immunity and Immunotherapy

Andong Li
Meiyu Wu
Ouyang Xie
Heng Xiang
Kehui Meng
Chongqing Tan
Long Wang
Xiaomin Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464092

1,457 views

Mini Review

Published on 09 Sep 2024

The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

in Cancer Immunity and Immunotherapy

Yongmei Wang
Saisai Li
Wenqin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436174

1,217 views

Brief Research Report

Published on 09 Sep 2024

Differential regulation of heparan sulfate biosynthesis in fibroblasts cocultured with normal vs. cancerous prostate cells

in Cancer Immunity and Immunotherapy

Elvira V. Grigorieva
Anastasia V. Strokotova
Ingemar Ernberg
Vladimir I. Kashuba

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440623

794 views

Correction

Published on 09 Sep 2024

Corrigendum: Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Martin Mucha
Martin Štach
Iva Kaštánková
Jana Rychlá
Jan Vydra
Petr Lesný
Pavel Otáhal

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483043

564 views

Original Research

Published on 09 Sep 2024

The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach

in Cancer Immunity and Immunotherapy

Jie Min
Fei Dong
Yongyuan Chen
Wenshan Li
Yimin Wu
Yanbin Tan
Fan Yang
Pin Wu
Ying Chai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379812

1,007 views

Review

Published on 06 Sep 2024

Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19

in Cancer Immunity and Immunotherapy

Qiaoyan Si
Mingjian Bai
Xiaolong Wang
Tianyu Wang
Yan Qin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420463

1,209 views

Original Research

Published on 06 Sep 2024

Immunological signatures from irradiated cancer-associated fibroblasts

in Cancer Immunity and Immunotherapy

Rodrigo Berzaghi
Kristian Gundersen
Brede Dille Pedersen
Amalie Utne
Nannan Yang
Turid Hellevik
Inigo Martinez-Zubiaurre

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433237

1,321 views

Review

Published on 06 Sep 2024

Dendritic cell-based immunotherapy in non-small cell lung cancer: a comprehensive critical review

in Cancer Immunity and Immunotherapy

Jamile Barboza de Oliveira
Saulo Brito Silva
Igor Lima Fernandes
Sabrina Setembre Batah
Andrea Jazel Rodriguez Herrera
Andrea de Cássia Vernier Antunes Cetlin
Alexandre Todorovic Fabro

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376704

1,781 views

Systematic Review

Published on 06 Sep 2024

Chimeric antigen receptor T-cell therapy in relapsed or refractory mantle cell lymphoma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Haixiang Wan
Songqin Weng
Sumei Sheng
Zilin Kuang
Qingming Wang
Linhui Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435127

1,343 views

Original Research

Published on 05 Sep 2024

TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Junyi Li
Meixue Chen
Ming Tong
Qingfei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457691

1,773 views
1 citation

Review

Published on 05 Sep 2024

Dysregulation of systemic immunity and its clinical application in gastric cancer

in Cancer Immunity and Immunotherapy

Yao Zhang
Junfeng Li
Jian Li
Jisheng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450128

847 views

Navigation group

Articles

Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study

Small molecule innate immune modulators in cancer therapy

Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma

Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States

The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

Differential regulation of heparan sulfate biosynthesis in fibroblasts cocultured with normal vs. cancerous prostate cells

Corrigendum: Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia

The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach

Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19

Immunological signatures from irradiated cancer-associated fibroblasts

Dendritic cell-based immunotherapy in non-small cell lung cancer: a comprehensive critical review

Chimeric antigen receptor T-cell therapy in relapsed or refractory mantle cell lymphoma: a systematic review and meta-analysis

TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma

Dysregulation of systemic immunity and its clinical application in gastric cancer